Schedule 13D ownership disclosure

OSIRIS THERAPEUTICS, INC.

Security class unavailable · CUSIP: 68827R108

Event date: 2018-07-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,810,455
Percent of class
42.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-046965
Form type
SC 13D/A
Filer
FRIEDLI PETER
CIK
CIK 1008317
Filed
Jul 25, 2018
Reporting period
Jul 05, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub